Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis
Zhigan Jiang(Second Military Medical University), Shuhui Chen(WuXi AppTec (China)), Deming Xu(WuXi AppTec (China)), Fengxun Guo(WuXi AppTec (China)), Jing Wang(Zunyi Medical University), Liang Shen(WuXi AppTec (China)), Haijun Li(University of Science and Technology of China), Jiliang Zhang(WuXi AppTec (China)), Xiao Zhang(Henan Academy of Sciences), Xing Liu, Jianhua Wang(Shaanxi Normal University), Zhiliang Yuan(National University of Singapore), Xiaoxin Chen(Guangdong Pharmaceutical University), Haiying He(Lanzhou University of Technology), Zhen Gong(Unknown), Lijuan Hou(Jiangsu Academy of Agricultural Sciences), Zhuowei Liu(Sun Yat-sen University), Jian Li(Sun Yat-sen University), Chaofeng Long(Guangdong Pharmaceutical University)
Cited by 7
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
Murine Mammary Carcinoma Exosomes Promote Tumor Growth by Suppression of NK Cell Function
|The Journal of Immunology|2006|487
Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic
|Translational Psychiatry|2020|312
The role of autophagy in bone metabolism and clinical significance
|Autophagy|2023|284
Exercise-Induced Neuroprotection of the Nigrostriatal Dopamine System in Parkinson's Disease
|Frontiers in Aging Neuroscience|2017|103